Hi @Von597
I am ER+ and HER2+ early stage, left breast and now in the latter stages of treatment after starting in March 2023.
I hear you, the timeframe can be daunting.
I was encouraged to hear treatment for HER2+ is very targeted and reportedly has excellent outcomes for early stage (based on trials).
It helped me to think in phases once all the diagnostics were done and my surgeon and oncologist shaped up the recommended plan.
Phase 1 was pre-surgery - 6 cycles of Herceptin, Perjeta, Docetaxel and carboplatin, in my case I was recommended to have chemo pre- surgery (“neo adjuvant”).
Regarding the cost of Perjeta my oncologist wrote to my health insurer supporting an application that they subsidise it and they did, a great result.
The next treatment phases depended on how I responded to the chemotherapy, but after that first phase I had surgery (lumpectomy) which was phase 2 for me, then I had phase 3, radiotherapy and I am now in what I consider phase 4, having the remaining cycles of a Herceptin and chemo combination called “ Kadcyla” but some people can finish out with Herceptin only. It is a long time but for me each has been more manageable as I have progressed.
A colleague in the same line of work who had been through HER2 + and ER+ treatment reached out and it was encouraging to know some tips to stay energised, rested, exercise and the boundaries for the work and it helped me feel motivated. I felt keeping an open mind for each phase has helped and whilst there have been side effects, the treatments and surgery have been effective and without complication, and my treating professionals have responded to make adjustments )to my doses or timing) when I hit an occasional hurdle.
All the best as you consider your options.